Ripasudil
From Infogalactic: the planetary knowledge core
File:Ripasudil.svg | |
Systematic (IUPAC) name | |
---|---|
4-Fluoro-5-{[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl}isoquinoline
|
|
Clinical data | |
Trade names | Glanatec |
Identifiers | |
PubChem | CID: 9863672 |
ChemSpider | 8039366 |
Synonyms | K-115 |
Chemical data | |
Formula | C15H18FN3O2S |
Molecular mass | 323.39 g/mol |
|
|
|
Ripasudil (Glanatec) is a drug used for the treatment of glaucoma and ocular hypertension. It is approved for use in Japan as a 0.4% ophthalmic solution.[1]
Ripasudil, a derivative of fasudil, is a rho kinase inhibitor.[2]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Ophthalmology drugs
- Protein kinase inhibitors
- Isoquinolines
- Sulfonamides
- Diazepanes
- Organofluorides
- Pharmacology stubs